S&S Healthcare Holding Ltd.
S&S Healthcare Holding Ltd. focuses on the research and development, manufacture, and sale of medical imaging devices in Taiwan, the United States, Switzerland, and internationally. It develops digital diagnostic X-ray systems; and researches, develops, and produces bone densitometry and body composition assessment products. The company was formerly known as Swissray Global Healthcare Holding Ltd… Read more
Market Cap & Net Worth: S&S Healthcare Holding Ltd. (4198)
S&S Healthcare Holding Ltd. (TWO:4198) has a market capitalization of $28.34 Million (NT$937.80 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #30512 globally and #1843 in its home market, demonstrating a -5.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying S&S Healthcare Holding Ltd.'s stock price NT$38.90 by its total outstanding shares 24108000 (24.11 Million).
S&S Healthcare Holding Ltd. Market Cap History: 2015 to 2026
S&S Healthcare Holding Ltd.'s market capitalization history from 2015 to 2026. Data shows change from $83.79 Million to $28.34 Million (-10.98% CAGR).
S&S Healthcare Holding Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how S&S Healthcare Holding Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
S&S Healthcare Holding Ltd.'s market cap is 0.08 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.70 Million | $181.73 Million | -$152.38 Million | 0.01x | N/A |
| 2020 | $30.68 Million | $101.36 Million | -$114.86 Million | 0.30x | N/A |
| 2021 | $4.55 Million | $122.35 Million | -$95.39 Million | 0.04x | N/A |
| 2022 | $19.31 Million | $254.44 Million | -$66.89 Million | 0.08x | N/A |
Competitor Companies of 4198 by Market Capitalization
Companies near S&S Healthcare Holding Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to S&S Healthcare Holding Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
S&S Healthcare Holding Ltd. Historical Marketcap From 2015 to 2026
Between 2015 and today, S&S Healthcare Holding Ltd.'s market cap moved from $83.79 Million to $ 28.34 Million, with a yearly change of -10.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$28.34 Million | +6.58% |
| 2025 | NT$26.60 Million | +14.06% |
| 2024 | NT$23.32 Million | +25.24% |
| 2023 | NT$18.62 Million | -3.58% |
| 2022 | NT$19.31 Million | +324.68% |
| 2021 | NT$4.55 Million | -85.18% |
| 2020 | NT$30.68 Million | +1037.84% |
| 2019 | NT$2.70 Million | -89.78% |
| 2018 | NT$26.38 Million | +14.44% |
| 2017 | NT$23.05 Million | -66.23% |
| 2016 | NT$68.25 Million | -18.55% |
| 2015 | NT$83.79 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of S&S Healthcare Holding Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.34 Million USD |
| MoneyControl | $28.34 Million USD |
| MarketWatch | $28.34 Million USD |
| marketcap.company | $28.34 Million USD |
| Reuters | $28.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.